Lupin Receives EIR from U.S. FDA for its Nagpur Unit-1 manufacturing facility
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
The delegation's visit covered a wide range of topics
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
Currently, Praveen Akkinepally is the Head of Lung Cancer Commercialization, AstraZeneca Gaithersburg, MD, USA
Alleviating staff shortages by empowering surgeons with greater personalization and control
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
The cognitively operated system is a mother patent invention, first launched in India
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Subscribe To Our Newsletter & Stay Updated